Interpreting methamphetamine levels in a high-use community

Environmental Science and Pollution Research

Volumn 18, Issue 9, 2011, Pages 1471-1477

  Chiaia Hernandez, Aurea C ^a   Banta Green, Caleb J ^b   Field, Jennifer A ^c  

^a SWISS FEDERAL INSTITUTE OF AQUATIC SCIENCE AND TECHNOLOGY   (Switzerland)

^b UNIVERSITY OF WASHINGTON   (United States)

^c OREGON STATE UNIVERSITY   (United States)

Author keywords

Drug use; Epidemiology wastewater; Methamphetamine (MA); Over the counter drugs; Temporal patterns; Wastewater treatment plants

Indexed keywords

DOSE-RESPONSE RELATIONSHIP; DRUG; DRUG PRESCRIBING; EPIDEMIOLOGY; HEALTH RISK; METABOLISM; PUBLIC HEALTH; SAMPLING; SPATIAL ANALYSIS; UNCERTAINTY ANALYSIS; WASTE TREATMENT; WASTEWATER;

EID: 85027921678     PISSN: 09441344     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11356-011-0495-3     Document Type: Article

References (54)

1. Banta-Green C, Field J, Chiaia A, Sudakin D, Power L, Montigny L (2009) Cocaine, methamphetamine and MDMA use by urbanicity-a demonstration using a population measure of community drug load derived from municipal wastewater in the State of Oregon. Addiction 104: 1874-1880.
2. Berset JD, Brenneisen R, Mathieu C (2010) Analysis of llicit and illicit drugs in waste, surface and lake water samples using large volume direct injection high performance liquid chromatography-electrospray tandem mass spectrometry (HPLC-MS/MS). Chemosphere 81: 859-866.
3. Bijlsma L, Sancho JV, Pitarch E, Ibanez M, Hernandez F (2009) Simultaneous ultra-high-pressure liquid chromatography-tandem mass spectrometry determination of amphetamine and amphetamine-like stimulants, cocaine and its metabolites, and a cannabis metabolite in surface water and urban wastewater. J Chromatogr A 1216: 3078-3089.
4. Boles TH, Wells MJM (2010) Analysis of amphetamine and methamphetamine as emerging pollutants in wastewater and wastewater-impacted streams. J Chromatogr A 1217: 2561-2568.
5. Castiglioni S, Zuccato E, Crisci E, Chiabrando C, Fanelli R, Bagnati R (2006) Identification and measurement of illicit drugs and their metabolites in urban wastewater by liquid chromatography-tandem mass spectrometry. Anal Chem 78: 8421-8429.
6. Cate W, Tony G, Rebecca M, Erin K, John L (2009) Methamphetamine use, dependence and treatment access in rural and regional North Coast of New South Wales, Australia. Drug Alcohol Rev 28: 592-599.
7. Caulkins J (2003) Methamphetamine epidemics: an empirical overview. Law Enforcement Executive Forum 3: 17-42. Available at: http://www. iletsbei. com/forum/articledetail. php?recordID=185.
8. Chiaia A, Banta-Green C, Field J (2008) Eliminating solid phase extraction with large-volume injection LC/MS/MS: analysis of illicit and legal drugs and human urine indicators in US wastewaters. Environ Sci Technol 42: 8841-8848.
9. Cloyd ML (1997) Diet pill metabolizes to d-methamphetamine. J Occup Med 39: 1135-1135.
10. Cody JT (1996) Enantiomeric composition of amphetamine and methamphetamine derived from the precursor compound famprofazone. Forensic Sci Int 80: 189-199.
11. Cody JT, Valtier S (1998) Detection of amphetamine and methamphetamine following administration of benzphetamine. J Anal Toxicol 22: 299-309.
12. Cook CE, Jeffcoat AR, Sadler BM, Hill JM, Voyksner RD, Pugh DE, White WR, Perez-Reyes M (1992) Pharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans. Drug Metab Dispos 20: 856-862.
13. Cook CE, Jeffcoat AR, Hill JM, Pugh DE, Patetta PK, Sadler BM, White WR, Perez-Reyes M (1993) Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. Drug Metab Dispos 21: 717-723.
14. Cruickshank CC, Dyer KR (2009) A review of the clinical pharmacology of methamphetamine. Addiction 104: 1085-1099.
15. Cunningham JK, Liu LM, Callaghan R (2009) Impact of US and Canadian precursor regulation on methamphetamine purity in the United States. Addiction 104: 441-453.
16. Cunningham JK, Bojorquez I, Campollo O, Liu L, Maxwell JC (2010) Mexico's methamphetamine precursor chemical interventions: impacts on drug treatment admissions. Addiction 105: 1973-1983.
17. Drug Enforcement Administration United States Department of Justice (2008) ARCOS: Automation of Reports and Consolidated Orders System, http://www. deadiversion. usdoj. gov/arcos/index. html.
18. European Monitoring Centre for Drugs and Drug Addiction (2009) Methamphetamine-a European Union perspective in the global context, http://www. europol. europa. eu/publications/Joint_publications_on_illicit_drugs/Methamphetamine. pdf. Accessed 1 Apr 2011.
19. Frost N, Griffiths P, Fanelli R (2008) Peering into dirty waters: the potential and implications of a new approach to monitoring drug consumption. Addiction 103: 1239-1241.
20. Hasegawa M, Matsubara K, Fukushima S, Maseda C, Uezono T, Kimura K (1999) Stereoselective analyses of selegiline metabolites: possible urinary markers for selegiline therapy. Forensic Sci Int 101: 95-106.
21. Hope R (2010) (Personal communication July 23, 2010) Assistant Director, Education Outreach, Oregon State University College of Pharmacy and Department of Human Services Division of Medical Assistance Program, Salem, OR.
22. Huerta-Fontela M, Galceran M, Ventura F (2008a) Stimulatory drugs of abuse in surface waters and their removal in a conventional drinking water treatment plant. Environ Sci Technol 42: 6809-6816.
23. Huerta-Fontela M, Galceran MT, Martin-Alonso J, Ventura F (2008b) Occurrence of psychoactive stimulatory drugs in wastewaters in north-eastern Spain. Sci Total Environ 397: 31-40.
24. Kasprzyk-Hordern B, Kondakal VVR, Baker DR (2010) Enantiomeric analysis of drugs of abuse in wastewater by chiral liquid chromatography coupled with tandem mass spectrometry. J Chromatogr A 1217: 4575-4586.
25. Kim I, Oyler JM, Moolchan ET, Cone EJ, Huestis MA (2004) Urinary pharmacokinetics of methamphetamine and its metabolite, amphetamine following controlled oral administration to humans. Ther Drug Monit 26: 664-672.
26. Lee JS, Yang WK, Han EY, Lee SY, Park YH, Lim MA, Chung HS, Park JH (2007) Monitoring precursor chemicals of methamphetamine through enantiomer profiling. Forensic Sci Int 173: 68-72.
27. Li LH, Everhart T, Jacob P, Jones R, Mendelson J (2010) Stereoselectivity in the human metabolism of methamphetamine. Br J Clin Pharmacol 69: 187-192.
28. Logan B (2002) Methamphetamine-effects on human performance and behavior. Forensic Sci Rev 14: 134-151.
29. Loganathan B, Phillips M, Mowery H, Jones-Lepp TL (2009) Contamination profiles and mass loadings of macrolide antibiotics and illicit drugs from a small urban wastewater treatment plant. Chemosphere 75: 70-77.
30. Maxwell JC, Rutkowski BA (2008) The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators, 1992-2007. Drug Alcohol Rev 27: 229-235.
31. McInerney-Leo A, Gwinn-Hardy K, Nussbaum RL (2004) Prevalence of Parkinson's disease in populations of African ancestry: a review. J Natl Med Assoc 96: 974-979.
32. Mendelson J, Uemura N, Harris D, Nath RP, Fernandez E, Jacob P, Everhart ET, Jones RT (2006) Human pharmacology of the methamphetamine stereoisomers. Clin Pharmacol Ther 80: 403-420.
33. National Drug Intelligence Center (2009) Oregon high intensity drug trafficking area drug market analysis, document: 2009-R0813-026, http://www. justice. gov/ndic/pubs32/32786/index. htm. Accessed 1 Apr 2011.
34. National Institute of Drug Abuse (2006) Assessing drug abuse within and across communities, community epidemiology surveillance networks on drug abuse, 2nd edn. National Institutes of Health, Bethesda, p 145, Publication no. 06-3614.
35. National Institute on Drug Abuse (2008) Epidemiologic trends in drug abuse-Proceedings of the community epidemiology work group highlights and executive summary NIH Publication No. 09-6420, Bethesda, MD, p. 59 http://www. drugabuse. gov/PDF/CEWG/AdvReport108. pdf.
36. National Institute on Drug Abuse (2010) Epidemiologic trends in drug abuse, Community Epidemiology Work Group. NIH Publication No. 10-7422.
37. Neugebauer M, Khedr A, ElRabbat N, ElKommos M, Saleh G (1997) Stereoselective metabolic study of famprofazone. Biomed Chromatogr 11: 356-361.
38. Nishida K, Itoh S, Inoue N, Kudo K, Ikeda N (2006) High-performance liquid chromatographic-mass spectrometric determination of methamphetamine and amphetamine enantiomers, desmethylselegiline and selegiline, in hair samples of long-term methamphetamine abusers or selegiline users. J Anal Toxicol 30: 232-237.
39. Office of Applied Studies (2007) The National Survey on Drug Use and Health (NSDUH) report: methamphetamine use. http://www. oas. samhsa. gov/2k7/meth/meth. cfm. Accessed 1 Apr 2011.
40. Oyler JM, Cone EJ, Joseph RE, Moolchan ET, Huestis MA (2002) Duration of detectable methamphetamine and amphetamine excretion in urine after controlled oral administration of methamphetamine to humans. Clin Chem 48: 1703-1714.
41. Postigo C, de Ada MJL, Barcelo D (2008a) Analysis of drugs of abuse and their human metabolites in water by LC-MS2: a non-intrusive tool for drug abuse estimation at the community level. Trac-Trends Anal Chem 27: 1053-1069.
42. Postigo C, Lopez de Alda MJ, Barcelo D (2008b) Fully automated determination in the low nanogram per liter level of different classes of drugs of abuse in sewage water by on-line solid-phase extraction-liquid chromatography-electrospray-tandem mass spectrometry. Anal Chem 80: 3123-3134.
43. Postigo C, de Alda MJL, Barcelo D (2010) Drugs of abuse and their metabolites in the Ebro River basin: occurrence in sewage and surface water, sewage treatment plants removal efficiency, and collective drug usage estimation. Environ Int 36: 75-84.
44. Proehl R (2009) 2008 Oregon population report. Population Research Center, College of Urban and Public Affairs, Portland State University, Portland, OR, p. 27 http://www. pdx. edu/sites/www. pdx. edu. prc/files/media_assets/PopRpt08c. pdf. Accessed 1 Apr 2011.
45. Romberg RW, Needleman SB, Snyder JJ, Greedan A (1995) Methamphetamine and amphetamine derived from the metabolism of selegiline. J Forensic Sci 40: 1100-1102.
46. Simon SL, Richardson K, Dacey J, Glynn S, Domier CP, Rawson RA, Ling W (2002) A comparison of patterns of methamphetamine and cocaine use. J Addict Dis 21: 35-44.
47. Stafford R, Radley D (2003) National trends in antiobesity medication use. Arch Intern Med 163: 1046-1050.
48. Sudakin D, Power LE (2009) Regional and temporal variation in methamphetamine-related incidents: applications of spatial and temporal scan statistics. Clin Toxicol 47: 243-247.
49. Tseng YL, Lin CT, Wang SM, Liu RH (2007) Famprofazone as the source of methamphetamine and amphetamine in urine specimen collected during sport competition. J Forensic Sci 52: 479-486.
50. United Nations Office on Drugs and Crime (2009) World Drug Report 2009, http://www. unodc. org/unodc/en/data-and-analysis/WDR-2009. html. Accessed 1 Apr 2011.
51. van Nuijs ALN, Pecceu B, Theunis L, Dubois N, Charlier C, Jorens PG, Bervoets L, Blust R, Neels H, Covaci A (2009a) Spatial and temporal variations in the occurrence of cocaine and benzoylecgonine in waste- and surface water from Belgium and removal during wastewater treatment. Water Res 43: 1341-1349.
52. van Nuijs ALN, Tarcomnicu I, Bervoets L, Blust R, Jorens PG, Neels H, Covaci A (2009b) Analysis of drugs of abuse in wastewater by hydrophilic interaction liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 395: 819-828.
53. Wolters Kluwer Health (2009) Drug facts and comparisons. Wolters Kluwer Health, St. Louis.
54. Zuccato E, Chiabrando C, Castiglioni S, Bagnati R, Fanelli R (2008) Estimating community drug abuse by wastewater analysis. Environ Health Perspect 116: 1027-1032.